You are using an outdated browser. Please upgrade your browser to improve your experience and security.
We uniquely create value in Healthcare, by fostering community, competencies and capital

A place where innovation happens

OpenZone is the embodiment of a place for the exchange of knowledge about research and enterprise. A campus funded entirely by private capital, dedicated to Health and founded on an approach geared towards open innovation. Conceived to build bridges between different competencies, languages, and worlds, it is a place where research is transformed into enterprise.

20,000
Square meters of office space
17,000
Square meters for laboratories
34
Businesses hosted
1,100
People
Elena Zambon
President @ Zambon S.p.A.

OpenZone, where Science Oxygen Business, was founded to build bridges and to encourage partnerships and the exchange of knowledge in Healthcare.

The campus is home to 34 Zoner enterprises
OpenZone is home to some of the foremost biotechnology, pharmaceutical, and advanced gene therapy companies in Italy and in the world.

WE ARE HIRING!

Companies at OpenZone are looking for new talents.
Send your application.


OpenZone is member of IASP  (International Association of Science Parks and Areas of Innovation), CEBR (Council of European BioRegion), InnovUp (Italian Innovation & Startup Ecosystem)  and Cluster Lombardo Lifescience.
 

Inspiring Story

OpenZone is more than just a space. It is also a place with stories that are worth telling, a scientific campus open to the exchange of knowledge and the sharing of ideas. Here, thanks to constant interaction between those who are a part of it, success stories are born and continue to evolve.

 
There is a lot of news to share about OpenZone and the businesses that call it home. Make sure you're always up-to-date.

The evolution of the femtech sector in 2023

Read more

WE ARE HIRING!

Read more

AGC Biologics to Manufacture First FDA-Approved Gene Therapy for Early-Onset MLD at OpenZone

Read more

Sibylla Biotech Enters a Strategic Drug Discovery Collaboration with Ono Pharmaceutical in Central Nervous System Disorders

Read more